LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $1.5M of Standard BioTools Inc.
Director and 10% owner
Bought$1,541,795
$2.57Price
600,000Shares
+1%Stake
What LAB did for a copier
- $1,000 copied at Wed, May 22 close, $2.59
- $714
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jul 8 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −8.2% against the S&P 500, and 7 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, May 20. Filed Wed, May 22, 3:53 PM ET, during the session. Returns use the May 22 close and the Jul 8 close. Not investment advice.